abstract |
The invention relates to the technical field of medicine, and relates to the preparation of ixazomib (Ixazomib, MLN2238) against tick-borne encephalitis virus (TBEV), West Nile virus (WNV), yellow fever virus (YFV) and chikungunya virus (CHIKV) infection drug application. Anti-TBEV, WNV, YFV and CHIKV infection drugs are ixazomib as the only active ingredient, or a pharmaceutical composition containing ixazomib. Anti-TBEV, WNV, YFV and CHIKV infection drugs refer to the prevention or treatment of TBEV, Drugs for WNV, YFV and CHIKV infections. |